Post-earnings recap
Reported
Thu, Feb 26, 2026
EPS actual
$1.53
EPS est.
$0.21
EPS surprise
+639.13%
1-day move
-3.19%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Aurinia Pharmaceuticals reported a significant earnings surprise with an EPS of $1.53, but the stock still fell by 3.19%. This decline may indicate investor concerns despite the strong EPS performance, possibly due to a lack of revenue information or future guidance. The market's reaction suggests that investors are looking for more comprehensive insights into the company's financial health.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.53 | N/A | +639.13% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.